These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 32592979)
21. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. Flores-Guerrero JL; Post A; van Dijk PR; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF Liver Int; 2021 Oct; 41(10):2371-2382. PubMed ID: 33993608 [TBL] [Abstract][Full Text] [Related]
22. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality. Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023 [TBL] [Abstract][Full Text] [Related]
23. Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism. Reiner MF; Müller D; Gobbato S; Stalder O; Limacher A; Bonetti NR; Pasterk L; Méan M; Rodondi N; Aujesky D; Angelillo-Scherrer A; Matter CM; Lüscher TF; Camici GG; von Eckardstein A; Beer JH Thromb Res; 2019 Feb; 174():40-47. PubMed ID: 30553164 [TBL] [Abstract][Full Text] [Related]
24. Trimethylamine-N-oxide and 5-year mortality: the role of gut microbiota-generated metabolite from the CORE-Thailand cohort. Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Sritara P; Phrommintikul A; Sci Rep; 2024 Sep; 14(1):21264. PubMed ID: 39261513 [TBL] [Abstract][Full Text] [Related]
25. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial. Cho CE; Taesuwan S; Malysheva OV; Bender E; Tulchinsky NF; Yan J; Sutter JL; Caudill MA Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27377678 [TBL] [Abstract][Full Text] [Related]
26. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804 [TBL] [Abstract][Full Text] [Related]
27. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine- Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424 [TBL] [Abstract][Full Text] [Related]
28. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure. Anderson KM; Ferranti EP; Alagha EC; Mykityshyn E; French CE; Reilly CM Heart Fail Rev; 2022 Nov; 27(6):2223-2249. PubMed ID: 35726110 [TBL] [Abstract][Full Text] [Related]
29. Association of Trimethylamine-N-Oxide Levels with Risk of Cardiovascular Disease and Mortality among Elderly Subjects: A Systematic Review and Meta-Analysis. Chen G; He L; Dou X; Liu T Cardiorenal Med; 2022; 12(2):39-54. PubMed ID: 34915483 [TBL] [Abstract][Full Text] [Related]
30. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort. Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696 [TBL] [Abstract][Full Text] [Related]
31. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease? He M; Tan CP; Xu YJ; Liu Y Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187 [TBL] [Abstract][Full Text] [Related]
32. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease. Chung SJ; Rim JH; Ji D; Lee S; Yoo HS; Jung JH; Baik K; Choi Y; Ye BS; Sohn YH; Yun M; Lee SG; Lee PH Nutrition; 2021 Mar; 83():111090. PubMed ID: 33418492 [TBL] [Abstract][Full Text] [Related]
33. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331 [TBL] [Abstract][Full Text] [Related]
34. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases? Nowiński A; Ufnal M Nutrition; 2018 Feb; 46():7-12. PubMed ID: 29290360 [TBL] [Abstract][Full Text] [Related]
35. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease. Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042 [TBL] [Abstract][Full Text] [Related]
36. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency. Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF Front Immunol; 2020; 11():574500. PubMed ID: 33042155 [TBL] [Abstract][Full Text] [Related]
37. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. Zhu Y; Li Q; Jiang H APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960 [TBL] [Abstract][Full Text] [Related]
38. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer. Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532 [TBL] [Abstract][Full Text] [Related]
39. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis. Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587 [TBL] [Abstract][Full Text] [Related]
40. Modulation of Circulating Trimethylamine N-Oxide Concentrations by Dietary Supplements and Pharmacological Agents: A Systematic Review. Kalagi NA; Abbott KA; Alburikan KA; Alkofide HA; Stojanovski E; Garg ML Adv Nutr; 2019 Sep; 10(5):876-887. PubMed ID: 31073588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]